Radiation pneumonitis in breast cancer patients treated with taxanes: Does sequential radiation therapy lower the risk?

Breast Journal

Volumn 11, Issue 5, 2005, Pages 317-320

  Beal, Kathryn ^a   Hudis, Clifford ^a   Norton, Larry ^a   Wagman, Raquel ^a   McCormick, Beryl ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast cancer; Radiation pneumonitis; Taxanes

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; PACLITAXEL; TAXANE DERIVATIVE; TRASTUZUMAB; TAXOID;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG SAFETY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LUNG TOXICITY; MASTECTOMY; METASTASIS; RADIATION DOSE; RADIATION PNEUMONIA; RETROSPECTIVE STUDY; RISK ASSESSMENT; SKIN TOXICITY; TREATMENT FAILURE; TREATMENT PLANNING; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGE DISTRIBUTION; AGED; BREAST TUMOR; CANCER STAGING; COHORT ANALYSIS; DOSE RESPONSE; HOSPITALIZATION; INCIDENCE; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIATION RESPONSE; SURVIVAL RATE;

ADULT; AGE DISTRIBUTION; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TAXOIDS;

EID: 27744566864     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1075-122X.2005.21696.x     Document Type: Article

References (16)

1. Henderson IC, Berry D, Demetri C, et al. Improved disease free survival and overall survival from the addition of sequential paclitaxel, but not from the escalation of doxorubicin dose level in the adjuvant chemotherapy of patients with node-positive primary breast cancer. Proc Am Soc Clin Oncol 1998;17:101a.
2. Boer K, Lang I, Szanto J, et al. Adjuvant therapy of breast cancer with docetaxel-containing combination (TAC) - a Hungarian experience in the BCIRG 001 trial. Pathol Oncol Res 2003;9:166-69.
3. Mamounas EP, Bryant J, Lembersky BC, et al. Paclitaxel (T) following doxorubicin/cyclophosphamide (AC) as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28 [abstract 12]. Proc Am Soc Clin Oncol 2003;22:4.
4. Adjuvant therapy for breast cancer. NIH Consensus Statement Online 2000 November 1-3;17(4):l-23; available at http:// consensus.nih.gov/cons/114/ 114_statement.htm.
5. Rathman J, Leoplod KA, Rigas JR. Daily paditaxeland thoracic radiation therapy for non-small cell lung cancer: preliminary results. Semin Radiat Oncol 1999;9(2 suppl 1):130-35.
6. Ettinger DS. Concurrent paclitaxel-containing regimens and thoracic radiation therapy for non-small cell lung cancer: preliminary results. Semin Radiat Oncol 1999;9:148-50.
7. Dowell JE, Sinard R, Yardley DA, et al. Seven-week continuous-infusion paclitaxel concurrent with radiation therapy for locally advanced non-small cell lung and head and neck cancers. Semin Radiat Oncol 1999;9(2 suppl 1):97-101.
8. Chen-Shou C, Hong L, McCormick B, et al. A simplified intensity modulated radiation therapy technique for the breast. Med Physics 2002;29:522-29.
9. Hanna YM, Baglan KL, Decker DA, et al. Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer patients. Breast J 2002;8:149-53.
10. Bellon JR, Lindsley KL, Seymour A, et al. Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer. Int J Radiat Oncol Biol Phys 2000;48:393-97.
11. Taghian AG, Assaad SI, Powell SN, et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 2001;93:1806-11.
12. Recht A, Cone SE, Henderson IC, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 1996;334:1356-61.
13. Kini VR, Vicini FA, Frazier R, Victor SJ, Wimbish K, Martinez AA. Mammographic, pathologic and treatment related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy, Int J Radiat Oncol Biol Phys 1999;43:241-46.
14. Formen SC, Symmans WF, Danenberg PV. Concurrent paclitaxel and radiation therapy for breast cancer. Semin Radiat Oncol 1999;9(suppl 1):34-42.
15. Mason KA, Hunter NR, Milas M, Abbruzzese JL, Milas L. Docetaxel enhances tumor radioresponse in vivo. Clin Cancer Res 1997;3:2431-38.
16. Zannelli GD, Quaia M, Rogieux I. Paclitaxel as a radiosensitizer: a proposed schedule of administration based on in vitro data and pharmacokinetic calculations. Eur J Cancer 1997;33:486-92.